Residential Construction
Compare Stocks
5 / 10Stock Comparison
UHG vs TMHC vs DHI vs LEN vs PHM
Revenue, margins, valuation, and 5-year total return — side by side.
Residential Construction
Residential Construction
Residential Construction
Residential Construction
UHG vs TMHC vs DHI vs LEN vs PHM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Residential Construction | Residential Construction | Residential Construction | Residential Construction | Residential Construction |
| Market Cap | $45M | $5.56B | $42.29B | $18.93B | $22.46B |
| Revenue (TTM) | $407M | $7.61B | $33.35B | $34.13B | $16.83B |
| Net Income (TTM) | $-16M | $672M | $3.17B | $2.08B | $2.04B |
| Gross Margin | 17.6% | 22.4% | 22.8% | 17.6% | 26.1% |
| Operating Margin | -0.0% | 13.2% | 11.8% | 7.7% | 16.4% |
| Forward P/E | — | 11.2x | 13.7x | 14.2x | 11.7x |
| Total Debt | $148M | $2.36B | $6.03B | $6.32B | $2.40B |
| Cash & Equiv. | $26M | $851M | $2.99B | $3.80B | $2.01B |
UHG vs TMHC vs DHI vs LEN vs PHM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| United Homes Group,… (UHG) | 100 | 12.5 | -87.5% |
| Taylor Morrison Hom… (TMHC) | 100 | 197.1 | +97.1% |
| D.R. Horton, Inc. (DHI) | 100 | 172.6 | +72.6% |
| Lennar Corporation (LEN) | 100 | 89.2 | -10.8% |
| PulteGroup, Inc. (PHM) | 100 | 233.3 | +133.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UHG vs TMHC vs DHI vs LEN vs PHM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, UHG doesn't own a clear edge in any measured category.
TMHC has the current edge in this matchup, primarily because of its strength in growth exposure and valuation efficiency.
- Rev growth -0.6%, EPS growth -6.0%, 3Y rev CAGR -0.4%
- PEG 0.34 vs LEN's 43.27
- -0.6% revenue growth vs UHG's -12.3%
- Lower P/E (11.2x vs 11.7x), PEG 0.34 vs 0.71
DHI is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.85, Low D/E 24.4%, current ratio 17.39x
- Beta 0.85, yield 1.1%, current ratio 17.39x
- Beta 0.85 vs UHG's 1.08, lower leverage
- +20.3% vs UHG's -30.7%
LEN is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.92, yield 2.3%
- 2.3% yield, 12-year raise streak, vs DHI's 1.1%, (2 stocks pay no dividend)
PHM ranks third and is worth considering specifically for long-term compounding.
- 5.7% 10Y total return vs DHI's 424.3%
- 12.1% margin vs UHG's -4.0%
- 11.4% ROA vs UHG's -5.8%, ROIC 17.2% vs -0.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.6% revenue growth vs UHG's -12.3% | |
| Value | Lower P/E (11.2x vs 11.7x), PEG 0.34 vs 0.71 | |
| Quality / Margins | 12.1% margin vs UHG's -4.0% | |
| Stability / Safety | Beta 0.85 vs UHG's 1.08, lower leverage | |
| Dividends | 2.3% yield, 12-year raise streak, vs DHI's 1.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +20.3% vs UHG's -30.7% | |
| Efficiency (ROA) | 11.4% ROA vs UHG's -5.8%, ROIC 17.2% vs -0.0% |
UHG vs TMHC vs DHI vs LEN vs PHM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
UHG vs TMHC vs DHI vs LEN vs PHM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PHM leads in 3 of 6 categories
TMHC leads 1 • LEN leads 1 • UHG leads 0 • DHI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PHM leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LEN is the larger business by revenue, generating $34.1B annually — 83.9x UHG's $407M. PHM is the more profitable business, keeping 12.1% of every revenue dollar as net income compared to UHG's -4.0%. On growth, DHI holds the edge at -2.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $407M | $7.6B | $33.3B | $34.1B | $16.8B |
| EBITDAEarnings before interest/tax | $2M | $1.0B | $4.0B | $2.8B | $2.8B |
| Net IncomeAfter-tax profit | -$16M | $672M | $3.2B | $2.1B | $2.0B |
| Free Cash FlowCash after capex | -$22M | $710M | $3.5B | $28M | $1.6B |
| Gross MarginGross profit ÷ Revenue | +17.6% | +22.4% | +22.8% | +17.6% | +26.1% |
| Operating MarginEBIT ÷ Revenue | -0.0% | +13.2% | +11.8% | +7.7% | +16.4% |
| Net MarginNet income ÷ Revenue | -4.0% | +8.8% | +9.5% | +6.1% | +12.1% |
| FCF MarginFCF ÷ Revenue | -5.3% | +9.3% | +10.5% | +0.1% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.5% | -26.8% | -2.3% | -6.5% | -12.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.2% | -51.2% | -13.2% | -52.5% | -30.4% |
Valuation Metrics
TMHC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 7.7x trailing earnings, TMHC trades at a 39% valuation discount to DHI's 12.6x P/E. Adjusting for growth (PEG ratio), TMHC offers better value at 0.23x vs LEN's 43.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $45M | $5.6B | $42.3B | $18.9B | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $167M | $7.1B | $45.3B | $21.4B | $22.9B |
| Trailing P/EPrice ÷ TTM EPS | -4.36x | 7.65x | 12.62x | 10.99x | 10.51x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.22x | 13.71x | 14.24x | 11.68x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.23x | 1.01x | 43.27x | 0.64x |
| EV / EBITDAEnterprise value multiple | 69.83x | 6.18x | 10.02x | 7.43x | 7.35x |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 0.68x | 1.23x | 0.55x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.25x | 0.95x | 1.83x | 1.02x | 1.80x |
| Price / FCFMarket cap ÷ FCF | — | 6.88x | 12.88x | 671.74x | 12.84x |
Profitability & Efficiency
PHM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
PHM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-23 for UHG. PHM carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to UHG's 2.57x. On the Piotroski fundamental quality scale (0–9), PHM scores 5/9 vs UHG's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -23.3% | +10.8% | +12.9% | +9.2% | +15.9% |
| ROA (TTM)Return on assets | -5.8% | +6.9% | +8.9% | +6.0% | +11.4% |
| ROICReturn on invested capital | -0.0% | +11.0% | +12.1% | +7.9% | +17.2% |
| ROCEReturn on capital employed | -0.0% | +13.2% | +13.1% | +8.8% | +20.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 2.57x | 0.37x | 0.24x | 0.29x | 0.19x |
| Net DebtTotal debt minus cash | $122M | $1.5B | $3.0B | $2.5B | $394M |
| Cash & Equiv.Liquid assets | $26M | $851M | $3.0B | $3.8B | $2.0B |
| Total DebtShort + long-term debt | $148M | $2.4B | $6.0B | $6.3B | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | -4.08x | 19.94x | 44.09x | 198.24x | 5590.17x |
Total Returns (Dividends Reinvested)
PHM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PHM five years ago would be worth $19,537 today (with dividends reinvested), compared to $1,253 for UHG. Over the past 12 months, DHI leads with a +20.3% total return vs UHG's -30.7%. The 3-year compound annual growth rate (CAGR) favors PHM at 20.8% vs UHG's -50.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.3% | +1.1% | +0.8% | -14.9% | -1.6% |
| 1-Year ReturnPast 12 months | -30.7% | +2.0% | +20.3% | -16.8% | +16.3% |
| 3-Year ReturnCumulative with dividends | -87.7% | +37.4% | +38.6% | -18.6% | +76.2% |
| 5-Year ReturnCumulative with dividends | -87.5% | +85.7% | +46.7% | -11.1% | +95.4% |
| 10-Year ReturnCumulative with dividends | -87.5% | +321.2% | +424.3% | +122.6% | +571.2% |
| CAGR (3Y)Annualised 3-year return | -50.2% | +11.2% | +11.5% | -6.6% | +20.8% |
Risk & Volatility
Evenly matched — TMHC and DHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
DHI is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than UHG's 1.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TMHC currently trades 82.0% from its 52-week high vs UHG's 25.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 0.92x | 0.85x | 0.92x | 1.01x |
| 52-Week HighHighest price in past year | $4.78 | $72.50 | $184.55 | $144.24 | $144.27 |
| 52-Week LowLowest price in past year | $0.99 | $54.58 | $114.17 | $83.03 | $95.20 |
| % of 52W HighCurrent price vs 52-week peak | +25.5% | +82.0% | +79.1% | +60.8% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 49.0 | 49.6 | 48.5 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 136K | 1.1M | 2.6M | 2.9M | 1.7M |
Analyst Outlook
LEN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TMHC as "Buy", DHI as "Hold", LEN as "Buy", PHM as "Hold". Consensus price targets imply 24.0% upside for TMHC (target: $74) vs 12.3% for DHI (target: $164). For income investors, LEN offers the higher dividend yield at 2.30% vs PHM's 0.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $73.75 | $163.86 | $102.14 | $141.22 |
| # AnalystsCovering analysts | — | 30 | 52 | 50 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.1% | +2.3% | +0.8% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 11 | 12 | 7 |
| Dividend / ShareAnnual DPS | — | — | $1.60 | $2.02 | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +6.9% | +10.1% | +9.6% | +5.5% |
PHM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TMHC leads in 1 (Valuation Metrics). 1 tied.
UHG vs TMHC vs DHI vs LEN vs PHM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UHG or TMHC or DHI or LEN or PHM a better buy right now?
For growth investors, Taylor Morrison Home Corporation (TMHC) is the stronger pick with -0.
6% revenue growth year-over-year, versus -12. 3% for United Homes Group, Inc. (UHG). Taylor Morrison Home Corporation (TMHC) offers the better valuation at 7. 7x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate Taylor Morrison Home Corporation (TMHC) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UHG or TMHC or DHI or LEN or PHM?
On trailing P/E, Taylor Morrison Home Corporation (TMHC) is the cheapest at 7.
7x versus D. R. Horton, Inc. at 12. 6x. On forward P/E, Taylor Morrison Home Corporation is actually cheaper at 11. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Taylor Morrison Home Corporation wins at 0. 34x versus Lennar Corporation's 43. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — UHG or TMHC or DHI or LEN or PHM?
Over the past 5 years, PulteGroup, Inc.
(PHM) delivered a total return of +95. 4%, compared to -87. 5% for United Homes Group, Inc. (UHG). Over 10 years, the gap is even starker: PHM returned +571. 2% versus UHG's -87. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UHG or TMHC or DHI or LEN or PHM?
By beta (market sensitivity over 5 years), D.
R. Horton, Inc. (DHI) is the lower-risk stock at 0. 85β versus United Homes Group, Inc. 's 1. 08β — meaning UHG is approximately 27% more volatile than DHI relative to the S&P 500. On balance sheet safety, PulteGroup, Inc. (PHM) carries a lower debt/equity ratio of 19% versus 3% for United Homes Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UHG or TMHC or DHI or LEN or PHM?
By revenue growth (latest reported year), Taylor Morrison Home Corporation (TMHC) is pulling ahead at -0.
6% versus -12. 3% for United Homes Group, Inc. (UHG). On earnings-per-share growth, the picture is similar: Taylor Morrison Home Corporation grew EPS -6. 0% year-over-year, compared to -131. 1% for United Homes Group, Inc.. Over a 3-year CAGR, PHM leads at 2. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UHG or TMHC or DHI or LEN or PHM?
PulteGroup, Inc.
(PHM) is the more profitable company, earning 12. 8% net margin versus -4. 0% for United Homes Group, Inc. — meaning it keeps 12. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHM leads at 17. 3% versus -0. 0% for UHG. At the gross margin level — before operating expenses — PHM leads at 26. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UHG or TMHC or DHI or LEN or PHM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Taylor Morrison Home Corporation (TMHC) is the more undervalued stock at a PEG of 0. 34x versus Lennar Corporation's 43. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Taylor Morrison Home Corporation (TMHC) trades at 11. 2x forward P/E versus 14. 2x for Lennar Corporation — 3. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TMHC: 24. 0% to $73. 75.
08Which pays a better dividend — UHG or TMHC or DHI or LEN or PHM?
In this comparison, LEN (2.
3% yield), DHI (1. 1% yield), PHM (0. 8% yield) pay a dividend. UHG, TMHC do not pay a meaningful dividend and should not be held primarily for income.
09Is UHG or TMHC or DHI or LEN or PHM better for a retirement portfolio?
For long-horizon retirement investors, D.
R. Horton, Inc. (DHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85), 1. 1% yield, +424. 3% 10Y return). Both have compounded well over 10 years (DHI: +424. 3%, UHG: -87. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UHG and TMHC and DHI and LEN and PHM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UHG is a small-cap quality compounder stock; TMHC is a small-cap deep-value stock; DHI is a mid-cap deep-value stock; LEN is a mid-cap deep-value stock; PHM is a mid-cap deep-value stock. DHI, LEN, PHM pay a dividend while UHG, TMHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.